The mechanism for the effects of atypical antipsychotics on the cognitive dysfunction of schizophreniavia the modulation of the function of the neuronal network
The mechanism for the effects of atypical antipsychotics on the cognitive dysfunction of schizophreniavia the modulation of the function of the neuronal network
批准号:
14370287
负责人:
KOYAMA Tsukasa
金额:
$8.9万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2002
资助国家:
日本
项目状态:
已结题
起止时间:
2002 至 2004
中文摘要
阐明精神分裂症认知功能障碍的发病机制和治疗机制非常重要,因为这种功能障碍会导致精神分裂症患者严重的社会功能障碍。苯环利定引起的前额叶皮质谷氨酸水平升高和多动障碍可被非典型抗精神病药物多沙平阻断。损毁将谷氨酸能神经元终末投射到前额叶皮质的背侧丘脑,增强了NMDA受体拮抗剂MK-801的行为和神经化学变化。另一种非典型抗精神病药奥氮平可增加前额叶皮质多巴胺D_1受体的蛋白水平,增强大鼠的工作记忆。因此,非典型抗精神病药可增强前额叶皮质N-甲基-D-天冬氨酸受体和多巴胺D_1受体的功能,有可能改善精神分裂症的认知功能障碍。
英文摘要
Clarifying the pathogenesis and the mechanism for the treatment of cognitive dysfunction of schizophrenia is important, because this dysfunction induces serious social dysfunction in patients with schizophrenia.Phencyclidine-induced increases in glutamate levels in the prefrontal cortex and hyperlocomotion were blocked by 5-HT2A receptor antagonist, an atypical antipsychotic, dozapine. Lesioning the mediodortsal thalamus, which projects the glutamatengic neuronal terminals to the prefrontal cortex, enhanced the behavioral and neurochemical changes of NMDA receptor antagonist, MK-801. Chronic administration of an another atypical antipsychotic, olanzapine increased protein level of dopamine D1 receptors in the prefrontal cortex, enhanced working memory of rats.Therefore, atypical antipsychotics, which can enhance the function of NMDA receptor and dopamine D1 receptor in the prefrontal cortex, may have a potential for improving the cognitive dysfunction of schizophrenia.
期刊论文(26)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
治療抵抗性分裂病への対処 薬物療法-Clozapine
治疗难治性精神分裂症 药物治疗 - 氯氮平
DOI:
--
发表时间:
2004
期刊:
Schizophrenia Frontier 4
影响因子:
--
作者:
[久住 一郎, 小山 司]
通讯作者:
小山 司
Abekawa T., Honda M., Ito K., Koyama T.: "Effects of NRA0045, a novel potent antagonist at dopamine D4,5-HT2A, and alphal adrenaline receptors and a selective D4 doapmine rece antagonist, on phencyclidine-induced behavior and glutamate release in rats"Psy
Abekawa T.、Honda M.、Ito K.、Koyama T.:“NRA0045(一种新型有效的多巴胺 D4、5-HT2A 和 α1 肾上腺素受体拮抗剂以及选择性 D4 多巴胺受体拮抗剂)对苯环己哌啶诱导的行为的影响
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
統合失調症の病態モデルと治療メカニズム〜治療抵抗性と治療メカニズム
精神分裂症的病理模型及治疗机制~治疗抵抗及治疗机制
DOI:
--
发表时间:
2004
期刊:
Schizophrenia Frontier 5
影响因子:
--
作者:
[安部川 智浩, 伊藤 侯輝, 小山司]
通讯作者:
小山司
DOI:
10.1007/s00213-005-2145-2
发表时间:
2005-06-01
期刊:
PSYCHOPHARMACOLOGY
影响因子:
3.4
作者:
[Fang, YR, Abekawa, T, Koyama, T]
通讯作者:
Koyama, T
統合失調症の病態モデルと治療メカニズム-治療抵抗性モデルと治療メカニズム
精神分裂症的病理模型和治疗机制-治疗抵抗模型和治疗机制
DOI:
--
发表时间:
2004
期刊:
Schizophrenia Frontier 5
影响因子:
--
作者:
[安部川 智浩, 伊藤 侯輝, 小山 司]
通讯作者:
小山 司
共 20 条
Study on the role of emotional stress for the pathogenesis of psychiatric disorders. -To clarify the relationship between emotional stress and central monoaminergic/peptidergic neural systems using animal models-
-
批准号:09470205
-
项目类别:Grant-in-Aid for Scientific Research (B).
-
资助金额:$8.32万
-
财政年份:1997
-
负责人:KOYAMA Tsukasa
-
依托单位:
Role of nitric oxide and glutamate in methamphetamine-induced psychosis
-
批准号:07457206
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$4.74万
-
财政年份:1995
-
负责人:KOYAMA Tsukasa
-
依托单位:
Neurochemical and pharmacological studies on the noves mode of action mechanisms of antipsychotic drugs : Preferential dopaminergic activation in the prefrontal cortex.
-
批准号:05454308
-
项目类别:Grant-in-Aid for General Scientific Research (B)
-
资助金额:$4.35万
-
财政年份:1993
-
负责人:KOYAMA Tsukasa
-
依托单位:
Animal Model of Neuroleptic Malignant Syndrome
-
批准号:01570598
-
项目类别:Grant-in-Aid for General Scientific Research (C)
-
资助金额:$1.34万
-
财政年份:1989
-
负责人:KOYAMA Tsukasa
-
依托单位:
海外基金